Cargando…

Abiraterone Acetate Attenuates SARS-CoV-2 Replication by Interfering with the Structural Nucleocapsid Protein

The drug repurposing strategy has been applied to the development of emergency COVID-19 therapeutic medicines. Current drug repurposing approaches have been directed against RNA polymerases and viral proteases. Recently, we found that the inhibition of the interaction between the SARS-CoV-2 structur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jinsoo, Hwang, Seok Young, Kim, Dongbum, Kim, Minyoung, Baek, Kyeongbin, Kang, Mijeong, An, Seungchan, Gong, Junpyo, Park, Sangkyu, Kandeel, Mahmoud, Lee, Younghee, Noh, Minsoo, Kwon, Hyung-Joo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Applied Pharmacology 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424333/ https://www.ncbi.nlm.nih.gov/pubmed/35548881 http://dx.doi.org/10.4062/biomolther.2022.037

Ejemplares similares

Apoptosis Enhances the Replication of Human Coronavirus OC43
por: Maharjan, Sony, et al.
Publicado: (2021)

Targeting the Interaction Between Spike Protein and Nucleocapsid Protein for Suppression and Detection of Human Coronavirus OC43
por: Kim, Jinsoo, et al.
Publicado: (2022)

MERS-CoV and SARS-CoV-2 replication can be inhibited by targeting the interaction between the viral spike protein and the nucleocapsid protein
por: Park, Byoung Kwon, et al.
Publicado: (2021)

Differential effect of SARS-CoV-2 infection on stress granule formation in Vero and Calu-3 cells
por: Kim, Dongbum, et al.
Publicado: (2022)

Production of SARS-CoV-2 N Protein-Specific Monoclonal Antibody and Its Application in an ELISA-Based Detection System and Targeting the Interaction Between the Spike C-Terminal Domain and N Protein
por: Kim, Dongbum, et al.
Publicado: (2021)

Production of a Monoclonal Antibody to the Nucleocapsid Protein of SARS-CoV-2 and Its Application to ELISA-Based Detection Methods with Broad Specificity by Combined Use of Detector Antibodies
por: Kim, Jinsoo, et al.
Publicado: (2022)

Analysis of spike protein variants evolved in a novel in vivo long-term replication model for SARS-CoV-2
por: Kim, Dongbum, et al.
Publicado: (2023)

Comparison of vaccination efficacy using live or ultraviolet-inactivated influenza viruses introduced by different routes in a mouse model
por: Baek, Kyeongbin, et al.
Publicado: (2022)

Abiraterone Acetate
Publicado: (2012)

MUC1-C influences cell survival in lung adenocarcinoma Calu-3 cells after SARS-CoV-2 infection
por: Kim, Dongbum, et al.
Publicado: (2021)

Differential Signaling and Virus Production in Calu-3 Cells and Vero Cells upon SARS-CoV-2 Infection
por: Park, Byoung Kwon, et al.
Publicado: (2021)

Anti-Bacterial Effect of CpG-DNA Involves Enhancement of the Complement Systems
por: Kim, Te Ha, et al.
Publicado: (2019)

Targeting TM4SF5 with anti-TM4SF5 monoclonal antibody suppresses the growth and motility of human pancreatic cancer cells
por: Park, Sangkyu, et al.
Publicado: (2020)

CpG-DNA induces bacteria-reactive IgM enhancing phagocytic activity against Staphylococcus aureus infection
por: Kim, Te Ha, et al.
Publicado: (2019)

A peptide-CpG-DNA-liposome complex vaccine targeting TM4SF5 suppresses growth of pancreatic cancer in a mouse allograft model
por: Park, Sangkyu, et al.
Publicado: (2018)

Abiraterone Acetate Withdrawal Syndrome: Does It Exist?
por: Gauthier, Hélène, et al.
Publicado: (2012)

A Mucin1 C-terminal Subunit-directed Monoclonal Antibody Targets Overexpressed Mucin1 in Breast Cancer
por: Wu, Guang, et al.
Publicado: (2018)

Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer
por: Chi, Kim N., et al.
Publicado: (2023)

Abiraterone Acetate and Castration Resistant Ductal Adenocarcinoma of the Prostate
por: Linden-Castro, Edgar, et al.
Publicado: (2014)

Macakurzin C Derivatives as a Novel Pharmacophore for Pan-Peroxisome Proliferator-Activated Receptor Modulator
por: Ko, Hyejin, et al.
Publicado: (2023)

Androgen dynamics and serum PSA in patients treated with abiraterone acetate
por: Ryan, C J, et al.
Publicado: (2014)

A case of abiraterone acetate withdrawal syndrome after initiation of upfront abiraterone therapy for high‐risk prostate cancer
por: Tani, Masaru, et al.
Publicado: (2023)

CD83 expression induced by CpG-DNA stimulation in a macrophage cell line RAW 264.7
por: Park, Min Chul, et al.
Publicado: (2013)

CpG-DNA exerts antibacterial effects by protecting immune cells and producing bacteria-reactive antibodies
por: Kim, Te Ha, et al.
Publicado: (2018)

The LACOG-0415 phase II trial: abiraterone acetate and ADT versus apalutamide versus abiraterone acetate and apalutamide in patients with advanced prostate cancer with non-castration testosterone levels
por: Werutsky, Gustavo, et al.
Publicado: (2019)

Abiraterone acetate, an inhibitor of adrenal androgen synthesis in “hormone refractory prostate cancer”
por: Goel, Arun Kumar, et al.
Publicado: (2011)

Open-label, phase I, pharmacokinetic studies of abiraterone acetate in healthy men
por: Acharya, M., et al.
Publicado: (2012)

Abiraterone Acetate: Targeting Persistent Androgen Dependence in Castration-Resistant Prostate Cancer
por: Harshman, Lauren C., et al.
Publicado: (2013)

Serious Hypokalemia Associated with Abiraterone Acetate in Patients with Castration-Resistant Prostate Cancer
por: Yamamoto, Yutaka, et al.
Publicado: (2018)

Adherence Patterns for Abiraterone Acetate and Concomitant Prednisone Use in Patients with Prostate Cancer
por: Lafeuille, Marie-Hélène, et al.
Publicado: (2014)

Identification of Novel Nucleocapsid Chimeric Proteins Inhibiting HIV-1 Replication
por: Kim, Hae-In, et al.
Publicado: (2022)

Effect of Previous COVID-19 Vaccination on Humoral Immunity 3 Months after SARS-CoV-2 Omicron Infection and Booster Effect of a Fourth COVID-19 Vaccination 2 Months after SARS-CoV-2 Omicron Infection
por: Kim, Jinsoo, et al.
Publicado: (2022)

Peritoneal Cells Mediate Immune Responses and Cross-Protection Against Influenza A Virus
por: Gautam, Avishekh, et al.
Publicado: (2019)

Abiraterone acetate: oral androgen biosynthesis inhibitor for treatment of castration-resistant prostate cancer
por: Rehman, Yasser, et al.
Publicado: (2012)

A Study on the Clinical Outcome of Abiraterone Acetate in Castration Resistant Prostate Cancer Patients
por: James, Aloysius, et al.
Publicado: (2018)

Abiraterone acetate for early stage metastatic prostate cancer: patient selection and special considerations
por: Castellan, Pietro, et al.
Publicado: (2018)

Abiraterone Acetate Complexes with Biometals: Synthesis, Characterization in Solid and Solution, and the Nature of Chemical Bonding
por: Buikin, Petr, et al.
Publicado: (2023)

Fatal fulminant hepatitis in a patient taking abiraterone acetate: a case report
por: Akpokavie, Dela, et al.
Publicado: (2023)

Niraparib with Abiraterone Acetate and Prednisone for Metastatic Castration-Resistant Prostate Cancer: Phase II QUEST Study Results
por: Chi, Kim N, et al.
Publicado: (2023)

Expression and characterization of transmembrane and coiled-coil domain family 3
por: Sohn, Wern-Joo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ravvthrojm1saotp7lkcmrg3i2